13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q2 2017. See the latest, Q2 2026 →
Reported value
$424.69B
+2.3% on the quarter before
Positions
2,189
208 new · 249 sold out
Top 10
14.3%
of the value
Est. gain
+$13.05B
on stocks held all quarter
Est. return
+3.4%
on those stocks since Q1 2017
Positions as of Jun 30, 2017, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2017. Striped tiles are options.
Largest buys
Since Q1 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Qualcomm~$1.83BAdded · 0.2% → 0.7%+33,098,753 shares
- Citigroup Inc~$1.71BAdded · 0.3% → 0.8%+25,638,860 shares
- Kinder Morgan~$763.3MAdded · 0.2% → 0.3%+39,840,402 shares
- Ubs Group Ag~$718.7MAdded · 0.2% → 0.3%+42,374,922 shares
- Meta~$573.7MAdded · 0.6% → 0.8%+3,799,517 shares
- Abbott Labs~$571.1MAdded · 0.4% → 0.6%+11,749,487 shares
- Hologic Inc~$425.4MAdded · 0.1% → 0.2%+9,374,421 shares
- Deutsche Bank Ag~$390.5MAdded · 0.1% → 0.2%+22,031,585 shares
- Lyondellbasell Industries N~$371.3MAdded · 0.0% → 0.1%+4,400,013 shares
- Cardinal Health Inc~$346.3MAdded · 0.8% → 0.8%+4,444,367 shares
Largest sells
Since Q1 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Medtronic Plc~$924.2MCut · 1.3% → 1.2%−10,413,397 shares
- Mondelez Intl Inc~$854.5MCut · 0.3% → 0.1%−19,785,566 shares
- Apple~$692.2MCut · 1.4% → 1.2%−4,806,178 shares
- Synchrony Finl~$685.5MCut · 0.3% → 0.1%−22,989,192 shares
- Csx Corp~$625.6MCut · 0.2% → 0.1%−11,466,684 shares
- Amazon~$600.0MCut · 0.5% → 0.4%−619,800 shares
- Merck & Co Inc~$578.3MCut · 1.8% → 1.6%−9,022,760 shares
- Panera Bread Co~$499.6MCut · 0.1% → 0.0%−1,587,577 shares
- Cisco~$493.7MCut · 0.9% → 0.7%−15,773,751 shares
- Lauder Estee Cos Inc~$456.0MCut · 0.2% → 0.1%−4,750,982 shares
Holdings
As of Jun 30, 2017. Changes are in shares against Mar 31, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb CoCOM · shares −1.0% · price +2.5% | 2.0% | $8.41B | +$202.3M | ||||||||
| MicrosoftCOM · shares −3.3% · price +4.7% | 1.9% | $8.23B | +$366.3M | ||||||||
| Merck & Co IncCOM · shares −7.8% · price +0.9% | 1.6% | $6.87B | +$58.9M | ||||||||
| Unitedhealth Group IncCOM · shares −2.2% · price +13.1% | 1.6% | $6.83B | +$788.9M | ||||||||
| Jpmorgan Chase & CoCOM · shares −2.8% · price +4.1% | 1.3% | $5.57B | +$216.8M | ||||||||
| Medtronic PlcSHS · shares −15% · price +10.2% | 1.2% | $5.14B | +$474.8M | ||||||||
| AppleCOM · shares −12% · price +0.3% | 1.2% | $5.11B | +$12.8M | ||||||||
| Allergan PlcSHS · shares −3.9% · price +1.7% | 1.2% | $5.03B | +$86.3M | ||||||||
| Wells Fargo Co NewCOM · shares −7.3% · price −0.4% | 1.2% | $4.99B | −$22.5M | ||||||||
| Eli LillyCOM · shares +1.9% · price −2.2% | 1.1% | $4.75B | −$102.6M | ||||||||
| Bank Amer CorpCOM · shares −3.5% · price +2.8% | 1.1% | $4.65B | +$128.4M | ||||||||
| Chubb LimitedCOM · shares −3.8% · price +6.7% | 1.1% | $4.64B | +$291.7M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −1.1% · price +3.9% | 1.1% | $4.59B | +$170.1M | ||||||||
| Chevron Corp NewCOM · shares −1.1% · price −2.8% | 1.0% | $4.35B | −$126.7M | ||||||||
| Johnson & JohnsonCOM · shares −1.8% · price +6.2% | 1.0% | $4.33B | +$253.2M | ||||||||
| Exxon Mobil CorpCOM · shares −3.3% · price −1.6% | 0.92% | $3.89B | −$61.7M | ||||||||
| IntelCOM · shares −1.5% · price −6.5% | 0.87% | $3.70B | −$255.7M | ||||||||
| Mckesson CorpCOM · shares −1.4% · price +11.0% | 0.87% | $3.69B | +$364.7M | ||||||||
| Cardinal Health IncCOM · shares +11% · price −4.5% | 0.80% | $3.42B | −$143.1M | ||||||||
| Pepsico IncCOM · shares +0.4% · price +3.2% | 0.80% | $3.41B | +$106.7M | ||||||||
| Comcast Corp NewCL A · shares −1.8% · price +3.5% | 0.79% | $3.34B | +$114.1M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares −1.6% · price +5.5% | 0.79% | $3.34B | +$174.3M | ||||||||
| Citigroup IncCOM NEW · shares +111% · price +11.8% | 0.77% | $3.27B | +$163.8M | ||||||||
| United Parcel Service IncCL B · shares −1.7% · price +3.1% | 0.75% | $3.19B | +$95.0M | ||||||||
| MetaCL A · shares +22% · price +6.3% | 0.75% | $3.19B | +$154.7M | ||||||||
| Total · 2,189 positions | 100% | $424.69B | +$13.05B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2017 to Q2 2017: 1,875 stocks held throughout, up $13.05B (+3.4%).
- Unitedhealth Group Inc+$788.9M+13%
- Regeneron Pharmaceuticals+$574.2M+27%
- Alibaba+$550.8M+31%
- Medtronic Plc+$474.8M+10%
- Microsoft+$366.3M+5%
- Schlumberger Ltd−$211.3M−16%
- Newfield Expl Co−$228.4M−23%
- Cisco−$239.4M−7%
- Intel−$255.7M−6%
- Anadarko Pete Corp−$322.9M−27%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |